Genetic test for lupus patients
Part of Immune system & allergy clinical trials.
This study looks at a gene that may be linked to lupus. It aims to understand how this gene affects the disease, which could help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lupus (SLE).
- You are willing to provide a blood or saliva sample for genetic testing.
- You do not have other autoimmune diseases or long-term inflammatory conditions.
- You are not pregnant or breastfeeding.
- You can give your informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests for a specific gene change (in the TREX1 gene) in people with lupus, especially those who have lupus-related skin rashes. It aims to understand how this gene may affect the disease.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study looks at how your genes can help create a personalized diet plan to manage lupus symptoms. The goal is to see if a diet based on your genetic makeup can help you live a healthier lifestyle.
This study looks at a type of immune cell in patients with active lupus. It may help doctors understand how lupus affects the immune system and could lead to better treatments.
This trial collects health data from people recently diagnosed with lupus to improve treatment and care. It is a registry study, not a drug-testing trial, and aims to understand how patients fare over time.
Hear when a new Systemic Lupus Erthematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.